Evidence map›Paper›PMID 22467495›Full record

ReviewEndocrinology2012

Minireview: The link between fat and bone: does mass beget mass?

Mone Zaidi, Christoph Buettner, Li Sun, Jameel Iqbal

Open access · bronzeAbstract readReview
In one paragraph

Review in Endocrinology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 72 citations in OpenAlex.

  1. Trial
  2. Associations between adiposity, hormones, and gains in height, whole-body height-adjusted bone size, and size-adjusted bone mineral content in 8- to 11-year-old children.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2016
    Trial
  3. Trial
  4. Article
  5. Article
  6. Bone, fat, and muscle interactions in health and disease.Archives of endocrinology and metabolism · 2022
    Review
  7. Article
  8. Review
  9. Obesity and Bone Loss at Menopause: The Role of Sclerostin.Diagnostics (Basel, Switzerland) · 2021
    Article
  10. Article
  11. Article
  12. First-in-class humanized FSH blocking antibody targets bone and fat.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Epitope-specific monoclonal antibodies to FSHβ increase bone mass.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mone ZaidiMount Sinai Bone Program and Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA. mone.zaidi@mountsinai.org
Christoph Buettner
Li Sun
Jameel Iqbal
Icahn School of Medicine at Mount Sinai · US

Funding

TSH and BoneR01DK080459 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DAVIES, TERRY FRANCIS, SUN, LI · 2009 to 2013
$2.8M
Exploring The Posterior Pituitary-Bone ConnectionR01AG040132 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ZAIDI, MONE · 2011 to 2015
$1.9M
Regulation of Adipose Tissue Metabolism by Central Insulin and LeptinR01DK083658 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BUETTNER, CHRISTOPH · 2009 to 2013
$1.9M
NIA NIH HHS R01 AG040132NIDDK NIH HHS R01 DK080459NIDDK NIH HHS R01 DK083658
6 · The paper itself

Abstract

Osteoporosis is less common in individuals with high fat mass. This putative osteoprotection is likely an adaptive mechanism that allows obese individuals to better carry their increased body mass. Recent studies have focused on hormones that link fat to bone. Adipokines, such as leptin, modulate bone cells through both direct and indirect actions, whereas molecules activating peroxisome proliferator-activated receptor γ drive mesenchymal stem cell differentiation towards adipocytes away from the osteoblastic lineage. There is emerging evidence that bone-derived osteocalcin regulates insulin release and insulin sensitivity and, hence, might indirectly affect fat mass. Despite these molecular connections between fat and bone, animal and human studies call into question a primary role for body fat in determining bone mass. Mice devoid of fat do not have a skeletal phenotype, and in humans, the observed correlations between bone and body mass are not just due to adipose tissue. An improved understanding of the integrative physiology at the fat-bone interface should allow us develop therapies for both osteoporosis and obesity.

Indexed as

Adipose TissueAnimalsBone and BonesBone DensityHumansLeptinOrgan SizeOsteoporosisLeptin

Identifiers

PMID22467495
PMCPMC3339646
OpenAlexW1971688939

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.